In other news, the FDA moves to restrict use of fluoride supplements by children and the EPA approves more pesticides that some consider PFAS ...
Aurinia Pharmaceuticals Inc. (AUPH) has recently garnered a “Buy” rating from Jefferies analyst Maury Raycroft, a change that could have significant implications for investors. With a target price of ...
Jefferies upgraded Aurinia Pharmaceuticals (AUPH) to Buy from Hold with a price target of $21, up from $10. The company’s commercial performance ...
20hOpinion
The FDA’s Meltdown Escalates
An ethics complaint leads to a resignation, and the agency shifts approval standards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback